Document is current

How the FDA approved an antipsychotic that failed to show a meaningful benefit but raised the risk of death

Crossref DOI link: https://doi.org/10.1136/bmj.p1801

Published Online: 2023-08-17

Update policy: https://doi.org/10.1136/crossmarkpolicy